Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Deep Vein Thrombosis Market Valued at Present and by 2029?

The market size for deep vein thrombosis has been experiencing consistent growth in the past few years. There will be an escalation from $1.06 billion in 2024 to around $1.09 billion in 2025, indicating a compound annual growth rate (CAGR) of 3.1%. This growth during the historic period is due to factors like the rise in vascular medicine specialization, the impact of medical guidelines, concentration on thrombosis prevention, advancement in clinical research, and a surge in diagnosis awareness.

The market size for deep vein thrombosis is predicted to experience consistent expansion in the following years, expanding to $1.3 billion by 2029 at a compound annual growth rate (CAGR) of 4.4%. This growth during the projected period can be linked to an increasing elderly populace, a heightened prevalence of lifestyle-related conditions, a considerable emphasis on proactive healthcare, innovative treatments, and a focus on patient-oriented care. Notable trends during this period include an increase in awareness of risk factors, advancements in diagnostic procedures, innovations in treatment methods, public health campaigns, and preventive measures post-surgery.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10616&type=smp

#What Drivers Are Influencing Growth In The Deep Vein Thrombosis Market?

The escalating count of persons necessitating deep vein thrombosis (DVT) treatments is predicted to boost the expansion of the deep vein thrombosis market in the future. DVT treatment involves the administration of medicines such as anticoagulants to patients diagnosed with DVT to thwart the development of novel blood clots and inhibit existing ones from enlarging, ultimately ameliorating the patient’s condition. The rise in patients needing DVT treatment signals a higher prevalence rate of DVT, thereby necessitating the need for DVT diagnostic, prevention, and treatment products. For example, the Centers for Disease Control and Prevention (CDC), a health agency based in the US, reported in February 2023 that approximately 900,000 people could be impacted by DVT annually in the United States. The report further stated that DVT or Pulmonary Embolism (PE) leads to the death of 60,000 to 100,000 Americans each year. Hence, the surge in individuals in need of deep vein thrombosis (DVT) treatment is fuelling the market’s growth.

What Are The Main Segments Identified In The Deep Vein Thrombosis Market Research?

The deep vein thrombosis market covered in this report is segmented –

1) By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class

2) By Treatment: Surgery, Drugs, Other Treatments

3) By Mode Of Administration: Injectable, Oral, Other Modes Of Action

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

5) By End User: Hospitals, Homecare, Specialty Clinics, Other End-users

Subsegments:

1) By Anticoagulants: Direct Oral Anticoagulants (DOACs), Vitamin K Antagonists, Low Molecular Weight Heparins, Unfractionated Heparin

2) By Inferior Vena Cava Filters: Retrievable IVC Filters, Permanent IVC Filters, Advanced IVC Filter Systems

3) By Other Drug Class: Thrombolytics, Antiplatelet Agents, Fibrinolytics, Combination Therapy

What Are The Leading Trends And Opportunities In The Deep Vein Thrombosis Sector?

Emerging innovations in products are becoming a prominent trend within the deep vein thrombosis market. Preeminent companies within this market are employing new technologies to devise novel products and secure their market standing. For instance, in January 2023, the USA-based innovative therapies developer, Penumbra Inc., introduced Lightning Flash, an advanced, powerful mechanical thrombectomy system for addressing venous and pulmonary thrombus. The system incorporates Penumbra’s unique lightning-intelligent aspiration technology and dual clot detection algorithms. It is engineered to promptly eliminate large blood clots present in the body, including venous thrombus and pulmonary emboli (PE). The system offers physicians a high torque-able, larger catheter that is geared towards effectively getting rid of substantial clot burdens in the pulmonary arteries or deep venous system while ensuring superior safety measures.

Which Companies Play A Key Role In The Development Of The Deep Vein Thrombosis Market?

Major companies operating in the deep vein thrombosis market include Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, Aspen Pharmacare Holdings Limited, Novartis AG, Mylan N.V., Bayer AG, Boehringer Ingelheim GmbH, Medtronic PLC, Hikma Pharmaceuticals PLC, Laboratorios Farmacéuticos Rovi S.A., Cardinal Health Inc., Teva Pharmaceutical Industries Ltd., AstraZeneca PLC, Stryker Corporation, Cook Medical Incorporated, Boston Scientific Corporation, Arjo AB, DJO Global Inc., Zimmer Biomet Holdings Inc., Devon Medical Products LLC, ThermoTek USA Inc., Pfizer Inc.

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report

What Are The Key Regional Developments Shaping The Deep Vein Thrombosis Market?

North America was the largest region in the deep vein thrombosis market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global deep vein thrombosis market report during the forecast period. The regions covered in the deep vein thrombosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10616&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model